Showing 361 - 380 results of 801 for search '"insulin resistance"', query time: 0.09s Refine Results
  1. 361

    Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes by Yuanjie Mao, Jen‐Tzer Gau, Ning Jiang

    Published 2025-01-01
    “…Materials and Methods Insulin resistance was calculated by estimated glucose disposal rate (eGDR). …”
    Get full text
    Article
  2. 362

    Determination of Irisin, Body Mass Index, and Other Biochemical Parameters in a Sample of Iraqi Type II Diabetic Patients by Takwa Al Koloob Ali Chachan, Huda Farhan, Shatha Hamed

    Published 2022-09-01
    “… Evidence suggests that Irisin, a peptide hormone, may play a role in lipid metabolism, insulin resistance, and obesity. On the other hand, its role in type 2 diabetic Mellitus [T2DM] in humans is uncertain. …”
    Get full text
    Article
  3. 363

    C-Peptide: A New Mediator of Atherosclerosis in Diabetes by Dusica Vasic, Daniel Walcher

    Published 2012-01-01
    “…Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. …”
    Get full text
    Article
  4. 364

    Hypercysteinemia, A Potential Risk Factor for Central Obesity and Related Disorders in Azores, Portugal by Ana Lima, Rita Ferin, Mafalda Bourbon, José Baptista, M. Leonor Pavão

    Published 2019-01-01
    “…Moreover, plasma Cys levels predicted waist circumference (β coefficient = 0.102, P=0.032) and concomitant central obesity and were also associated with insulin resistance. Nevertheless, hyperhomocysteinemia prevalence was similar in both groups, despite the fact that PDL subjects exhibited a higher rate of vitamin B12 deficiency compared to those from Lisbon (19% vs. 6%, P=0.003). …”
    Get full text
    Article
  5. 365

    Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice by Sorim Choung, Kyong Hye Joung, Bo Ram You, Sang Ki Park, Hyun Jin Kim, Bon Jeong Ku

    Published 2018-01-01
    “…Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance. The peroxisome proliferator-activated receptor (PPAR) activators, thiazolidinediones, (TZDs), are insulin sensitizers used as a treatment for NAFLD. …”
    Get full text
    Article
  6. 366

    Effect of weight loss on the course of non-alcoholic fatty liver disease: results of 6-month follow-up by L. V. Chesnokova, I. M. Petrov, I. A. Troshina, M. V. Goncharova, I. V. Medvedeva

    Published 2015-03-01
    “…Weight loss for 5% and over at steatosis stage of NAFLD is characterized by decrease ofbiochemical cardio-vascular risk markers, in addition the group with 40 min/day physical exercises inefficacy had lower level of insulin resistance index and TNF-α along with higher levels of NO metabolites.…”
    Get full text
    Article
  7. 367

    Assessment of Zinc Alpha-2 Glycoprotein Level in Gestational Diabetes Woman in Respect to Glycemic Status with and without Treatment by Bara Nahdh Saleem, Manal Khalid Abdulridha, Hind Abdalkhaliq Showman, Manal Sabbar

    Published 2025-01-01
    “…It is distinguished by substantial insulin resistance induced by the secretion of placental hormone. …”
    Get full text
    Article
  8. 368

    Triglyceride Glucose Index Was a Predictor of 6-Month Readmission Caused by Pulmonary Infection of Heart Failure Patients by Licheng Shi, Jianan Liu, Xuanfeng Zhu, Tiantian Li, Jingli Wen, Xinyu Wang, Xu Qi

    Published 2022-01-01
    “…Objectives. Insulin resistance is associated with the prognosis of heart failure (HF) patients. …”
    Get full text
    Article
  9. 369

    Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications by Alina Mihaela Leustean, Manuela Ciocoiu, Anca Sava, Claudia Florida Costea, Mariana Floria, Claudia Cristina Tarniceriu, Daniela Maria Tanase

    Published 2018-01-01
    “…Key factors that cause cardiovascular disease in people with diabetes include hyperglycemia, dyslipidemia, obesity, insulin resistance, inflammation, hypertension, autonomic dysfunction, and decreased vascular response capacity. …”
    Get full text
    Article
  10. 370

    L-Arginine Supplementation in Type II Diabetic Rats Preserves Renal Function and Improves Insulin Sensitivity by Altering the Nitric Oxide Pathway by Taylor Claybaugh, Sarah Decker, Kelly McCall, Yuriy Slyvka, Jerrod Steimle, Aaron Wood, Megan Schaefer, Jean Thuma, Sharon Inman

    Published 2014-01-01
    “…These results suggest the importance of the NO pathway in consequent renal dysfunction and in the development of insulin resistance in diabetic rats.…”
    Get full text
    Article
  11. 371

    Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction by Hernán Gonzalo Villagarcía, Vanesa Sabugo, María Cecilia Castro, Guillermo Schinella, Daniel Castrogiovanni, Eduardo Spinedi, María Laura Massa, Flavio Francini

    Published 2016-01-01
    “…In conclusion adult MSG rats developed an insulin-resistant state and increased OS and serious hepatic dysfunction characterized by inflammation and metabolic signs suggesting increased lipogenesis. …”
    Get full text
    Article
  12. 372

    Protective Role of Picralima nitida Seed Extract in High-Fat High-Fructose-Fed Rats by Opeyemi Christianah De Campos, Daniel Ikpomwosa Osaigbovo, Titilayo Ifeoluwa Bisi-Adeniyi, Franklyn Nonso Iheagwam, Solomon Oladapo Rotimi, Shalom Nwodo Chinedu

    Published 2020-01-01
    “…APN caused a significant decrease (P<0.05) in weight gained, body mass index, insulin resistance, plasma glucose, and insulin levels. …”
    Get full text
    Article
  13. 373

    Metabolic Profile in a Cohort of Young Sicilian Patients with Klinefelter’s Syndrome: The Role of Irisin by Stefano Radellini, Valentina Guarnotta, Vincenzo Sciabica, Giuseppe Pizzolanti, Carla Giordano

    Published 2022-01-01
    “…Irisin blood levels of Klinefelter’s patients are higher than in healthy subjects and positively correlate with the degree of insulin resistance.…”
    Get full text
    Article
  14. 374

    Role of NKT Cells in the Pathogenesis of NAFLD by Kazuto Tajiri, Yukihiro Shimizu

    Published 2012-01-01
    “…NKT cells may have a protective role at the early stage with simple steatosis through modification of insulin resistance, whereas they act as a progression factor at the advanced stage with fibrosis. …”
    Get full text
    Article
  15. 375

    Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS) by Pascal Froment, Philippe Touraine

    Published 2006-01-01
    “…The positive action of the insulin-sensitizing treatments could be explained by a decrease in the peripheral insulin resistance but also by a direct action at the ovarian level. …”
    Get full text
    Article
  16. 376

    Utilization of edible poultry slaughter residues: A chicken-liver hydrolysate with glucose-lowering ability and upregulating glycogenesis in type II diabetes by Yi-Ling Lin, Yu-Pei Chen, Sheng-Yao Wang, Yi-Feng Kao, Chompunut Lumsangkul, Yi-Chen Chen

    Published 2025-01-01
    “…In db/db mice, CLH supplementation improved insulin resistance, as shown by OGTT assay, HOMA-IR value and serum glucose levels, while also reducing serum lipids and liver damage indices (p<0.05). …”
    Get full text
    Article
  17. 377

    Pre-diabetes and cardiovascular risk factors in NAFLD patients: a retrospective comparative analysis by Azam Teimouri, Zahra Ebrahimpour, Awat Feizi, Bijan Iraj, Elahe Saffari, Mojtaba Akbari, Mozhgan Karimifar

    Published 2025-02-01
    “…ObjectivesInsulin resistance plays a critical role in the pathophysiology of diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). …”
    Get full text
    Article
  18. 378

    The Use of SGLT-2 Inhibitors and GLP-1RA in Frail Older People with Diabetes: A Personalised Approach Is Required by Alan J. Sinclair, Ahmed H. Abdelhafiz

    Published 2025-01-01
    “…The frailty syndrome appears to span across a spectrum, from a sarcopenic obese phenotype at one end, characterised by obesity, insulin resistance, and prevalent cardiovascular risk factors, to an anorexic malnourished phenotype at the other end, characterised by significant weight loss, reduced insulin resistance, and less prevalent cardiovascular risk factors. …”
    Get full text
    Article
  19. 379

    Adipocyte DIO2 Expression Increases in Human Obesity but Is Not Related to Systemic Insulin Sensitivity by David Bradley, Joey Liu, Alecia Blaszczak, Valerie Wright, Anahita Jalilvand, Bradley Needleman, Sabrena Noria, David Renton, Willa Hsueh

    Published 2018-01-01
    “…Our results suggest that adipocyte-derived DIO2 may play a role in weight maintenance but is likely not a major contributor to obesity-related insulin resistance.…”
    Get full text
    Article
  20. 380

    Classic and Novel Sex Hormone Binding Globulin Effects on the Cardiovascular System in Men by Carla Basualto-Alarcón, Paola Llanos, Gerardo García-Rivas, Mayarling Francisca Troncoso, Daniel Lagos, Genaro Barrientos, Manuel Estrada

    Published 2021-01-01
    “…Circulating SHBG levels are influenced by metabolic and hormonal factors, and they are reduced in obesity and insulin resistance, suggesting that SHBG may have a broader clinical utility in assessing the risk for cardiovascular diseases. …”
    Get full text
    Article